Alex Goldberg

Gilead Sciences Inc. (NASDAQ:GILD) and Comcast Corporation (NASDAQ:CMCSA) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/10/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Gilead Sciences Inc. (NASDAQ:GILD) and Comcast Corporation (NASDAQ:CMCSA).

Gilead Sciences Inc. (NASDAQ:GILD) a biopharmaceutical company that discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia is currently down (-0.12%) on 3,607,766 shares traded after GILEAD SCIENCES INC Filed SEC form 8-K, Change in Directors or Principal Officers. Gilead Sciences Inc. (NASDAQ:GILD) is currently down (-3.4%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Gilead Sciences Inc. (NASDAQ:GILD)

Comcast Corporation (NASDAQ:CMCSA) operates as a media and technology company worldwide is currently up (+0.93%) on 5,057,579 shares traded after Live Nation and Comcast Extended Partnership, Naming Agreement. Comcast Corporation (NASDAQ:CMCSA) is currently up (+41.47%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Comcast Corporation (NASDAQ:CMCSA)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com